title: How often hepatocellular carcinoma has a typical pattern in contrast enhanced ultrasound?
abstract: OBJECTIVE
  Contrast Enhanced Ultrasound is an imaging method that can evaluate imediatelly focal liver lesions discovered by ultrasound.The aim of this study is to demonstrate if Contrast Enhanced Ultrasound can be reliable as a diagnostic method for hepatocellular carcinoma.
  
  
  METHODS
  We included in our retrospective monocentric study all patients evaluated in our Department during 2 years, which had hepatocellular carcinoma as final diagnosis (using Contrast Enhanced Ultrasound, Contrast Enhanced Computed Tomography, Magnetic Resonance Imaging or biopsy). 91 patients with chronic liver diseases were evaluated, with a total of 114 liver nodules. The enhancement pattern of the nodules was evaluated according to the 2008 guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology. The lesions with arterial enhancement and washout in the portal or late phase were considered hepatocellular carcinoma. The nodules were classified according to their size in ≤3 cm and >3 cm.
  
  
  RESULTS
  Of all nodules, 103 had hyperenhancing arterial pattern and washout was observed in 79 cases. In our study, this method established the diagnosis of hepatocellular carcinoma in 45 of 55 cases with liver nodules larger than 3 cm (81.8%) vs. 34 of 59 cases with nodules smaller than 3 cm (57.6%) (p<0.001).
  
  
  CONCLUSIONS
  69.3% of all hepatocellular carcinoma had a typical enhancement pattern on Contrast Enhanced Ultrasound, performing better in nodules larger than 3 cm, than in smaller nodules (p<0.001).
authors: Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy Timisoara, Romania.
authors: Alina
authors: A
authors: Martie
authors: Ioan
authors: I
authors: Sporea
authors: Roxana
authors: R
authors: Sirli
authors: Alina
authors: A
authors: Popescu
authors: Mirela
authors: M
authors: Danila
keywords: Contrast Enhanced Ultrasound; hepatocellular carcinoma; vascular phases
references: Med Ultrason. 2010 Sep;12(3):233-7
references: 21203602
references: Radiology. 2001 Sep;220(3):661-7
references: 11526264
references: Invest Radiol. 2000 Jan;35(1):80-5
references: 10639039
references: Ultraschall Med. 2008 Oct;29(5):499-505
references: 19241506
references: Ultraschall Med. 2008 Feb;29(1):28-44
references: 18270887
references: AJR Am J Roentgenol. 2009 Jul;193(1):55-60
references: 19542395
references: Radiology. 2004 Sep;232(3):799-809
references: 15284434
references: AJR Am J Roentgenol. 2009 Dec;193(6):W482-9
references: 19933622
references: J Clin Ultrasound. 2010 Jan;38(1):1-9
references: 19790253
references: Ultraschall Med. 2009 Aug;30(4):383-9
references: 19688670
references: Ultraschall Med. 2010 Oct;31(5):492-9
references: 20652854
references: AJR Am J Roentgenol. 2004 Nov;183(5):1319-26
references: 15505297
references: Invest Radiol. 2007 Aug;42(8):596-603
references: 17620943
references: Radiology. 2007 Sep;244(3):898-906
references: 17709836
references: Dig Liver Dis. 2007 Feb;39(2):187-95
references: 17208526
references: Ultraschall Med. 2004 Aug;25(4):249-56
references: 15300497
references: Radiographics. 2004 Jul-Aug;24(4):921-35
references: 15256618
references: Ultraschall Med. 2009 Aug;30(4):376-82
references: 19688669
references: J Med Ultrason (2001). 2010 Jul;37(3):97-106
references: 27278008
references: J Gastrointestin Liver Dis. 2010 Dec;19(4):393-8
references: 21188330
references: AJR Am J Roentgenol. 2002 Nov;179(5):1273-9
references: 12388513
references: Oncologist. 2010;15 Suppl 4:1-4
references: 21115575
references: Oncologist. 2010;15 Suppl 4:5-13
references: 21115576
references: Med Ultrason. 2010 Dec;12(4):280-5
references: 21210012